Transcription of PRODUCT MONOGRAPH - Sanofi
{{id}} {{{paragraph}}}
PLAVIX PRODUCT MONOGRAPH Page 1 of 55 PRODUCT MONOGRAPH PrPLAVIX Clopidogrel Tablets, Manufacturer s Standard 75 and 300 mg Clopidogrel, as clopidogrel bisulfate Platelet Aggregation Inhibitor Sanofi -aventis Canada Inc. 2905 Place Louis-R. Renaud Laval (Qu bec) H7V 0A3 Date of Revision: March 9, 2018 Submission Control No: 211788 s-a Version dated March 9, 2018 PLAVIX PRODUCT MONOGRAPH Page 2 of 55 Table of Contents PART I: HEALTH PROFESSIONAL INFORMATION .. 3 SUMMARY PRODUCT INFORMATION .. 3 INDICATIONS AND CLINICAL USE .. 3 CONTRAINDICATIONS .. 4 WARNINGS AND PRECAUTIONS .. 4 ADVERSE REACTIONS .. 7 DRUG INTERACTIONS .. 16 DOSAGE AND ADMINISTRATION .. 21 OVERDOSAGE .. 21 ACTION AND CLINICAL PHARMACOLOGY.
PLAVIX Product Monograph Page 1 of 55 . PRODUCT MONOGRAPH . PrPLAVIX®. Clopidogrel Tablets, Manufacturer’s Standard . 75 …
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}